Amedisys (NASDAQ:AMED) Posts Earnings Results, Misses Expectations By $0.19 EPS

Amedisys (NASDAQ:AMED) posted its quarterly earnings results on Wednesday. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19), Briefing.com reports. The company had revenue of $587.67 million during the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $0.98 earnings per share.

Amedisys Price Performance

Shares of NASDAQ AMED traded down $0.91 during trading hours on Thursday, hitting $96.80. 371,727 shares of the stock were exchanged, compared to its average volume of 337,228. The company’s fifty day simple moving average is $96.75 and its two-hundred day simple moving average is $95.77. The company has a market cap of $3.17 billion, a PE ratio of 34.90, a price-to-earnings-growth ratio of 1.87 and a beta of 0.78. Amedisys has a 1-year low of $89.55 and a 1-year high of $98.95. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AMED. Deutsche Bank Aktiengesellschaft downgraded Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research report on Monday, July 29th. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a research report on Thursday, July 25th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.